{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:28:13Z","timestamp":1777872493441,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603429"],"award-info":[{"award-number":["81603429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473471"],"award-info":[{"award-number":["81473471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603429,81473471"],"award-info":[{"award-number":["81603429,81473471"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jep.2020.112660","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T12:13:26Z","timestamp":1581596006000},"page":"112660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKII\u03b4 and ERK1\/2 pathways"],"prefix":"10.1016","volume":"253","author":[{"given":"Jianyong","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dancai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiashin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2020.112660_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12964-014-0078-2","article-title":"Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation","volume":"12","author":"Aguiar","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jep.2020.112660_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","article-title":"CaMKII in myocardial hypertrophy and heart failure","volume":"51","author":"Anderson","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2020.112660_bib3","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jep.2020.112660_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.114.010686","article-title":"Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+\/calmodulin-dependent protein kinase II signaling","volume":"131","author":"Bisserier","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jep.2020.112660_bib6","first-page":"1","article-title":"Chinese cardiovascular disease report","volume":"33","author":"Chen","year":"2018","journal-title":"Chin. Circulat. J."},{"key":"10.1016\/j.jep.2020.112660_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging","volume":"9","author":"de Lucia","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2020.112660_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00395-016-0574-1","article-title":"Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure","volume":"111","author":"Deng","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jep.2020.112660_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-11-80","article-title":"Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication","volume":"11","author":"Gupta","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jep.2020.112660_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/scitranslmed.aao0144","article-title":"Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism","volume":"10","author":"Jeong","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jep.2020.112660_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13063-019-3308-5","article-title":"Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial","volume":"20","author":"Jiang","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.jep.2020.112660_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-018-0700-3","article-title":"Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress","volume":"113","author":"Kazakov","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jep.2020.112660_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00639","article-title":"Overexpression of miR-221 in sudden death with cardiac hypertrophy patients","volume":"4","author":"Kakimoto","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.jep.2020.112660_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12576-017-0557-5","article-title":"Investigating \u03b2-adrenergic-induced cardiac hypertrophy through computational approach: classical and non-classical pathways","volume":"68","author":"Khalilimeybodi","year":"2018","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.jep.2020.112660_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/CIRCULATIONAHA.114.006185","article-title":"Cardiac CaM Kinase II genes \u03b4 and \u03b3 contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy","volume":"130","author":"Kreusser","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jep.2020.112660_bib17","first-page":"488","article-title":"Isolariciresinol-9'-O-\u03b1-L-arabinofuranoside protects against hydrogen peroxide-induced apoptosis of human umbilical vein endothelial cells via a PI3K\/Akt\/Bad-dependent pathway","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jep.2020.112660_bib18","first-page":"23","article-title":"Effect of songling xuemai kang on hyperlipidemia and hypertension","volume":"24","author":"Liu","year":"2004","journal-title":"Harbin Med. Univ."},{"key":"10.1016\/j.jep.2020.112660_bib19","first-page":"1322","article-title":"Regulatory mechanism of Songling Xuemaikang Capsule on RAAS system in spontaneously hypertensive rats","volume":"30","author":"Liu","year":"2015","journal-title":"Chin. J. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2020.112660_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jep.2020.112660_bib21","first-page":"80","article-title":"UPLC fingerprint and components identification of Songling Xuemaikang capsules by LC-MS\/MS","volume":"28","author":"Qi","year":"2013","journal-title":"West China J. Pharm. Sci."},{"key":"10.1016\/j.jep.2020.112660_bib22","first-page":"71","article-title":"Differential expression of 14-3-3\u03b5 during physiological, pathological cardiac hypertrophy and chronic heart failure in mice","volume":"13","author":"Qi","year":"2009","journal-title":"Gene Ther. Mol. Biol."},{"key":"10.1016\/j.jep.2020.112660_bib23","doi-asserted-by":"crossref","first-page":"108958","DOI":"10.18632\/oncotarget.22440","article-title":"Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia in vivo and in vitro","volume":"8","author":"Qi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jep.2020.112660_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2016.06.007","article-title":"CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift","volume":"98","author":"Uchinoumi","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2020.112660_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-018-9676-1","article-title":"Protein tyrosine phosphatases in cardiac physiology and pathophysiology","volume":"23","author":"Wade","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.jep.2020.112660_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13880209.2018.1563619","article-title":"Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats","volume":"57","author":"Yang","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jep.2020.112660_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11655-014-1709-6","article-title":"Songling Xuemaikang Capsule for primary hypertension: a systematic review of randomized controlled trials","volume":"21","author":"Yang","year":"2015","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.jep.2020.112660_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cvr\/cvv108","article-title":"Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy","volume":"106","author":"Zhong","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jep.2020.112660_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.06.010","article-title":"Role of CaMKII in free fatty acid\/hyperlipidemia-induced cardiac remodeling both in vitro and in vivo","volume":"109","author":"Zhong","year":"2017","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874119325462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874119325462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:41:30Z","timestamp":1777570890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874119325462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"alternative-id":["S0378874119325462"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2020.112660","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKII\u03b4 and ERK1\/2 pathways","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2020.112660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112660"}}